What Researchers Did
Researchers utilized hyperbaric oxygen therapy in a single case of severe rhinocerebral mucormycosis in a patient who had refused radical surgery.
What They Found
The rapid progression of mucormycosis was arrested, with post-therapy tissue cultures showing only bacterial contaminants instead of Rhizopus. The patient survived for 3 months before succumbing to Pseudomonas meningitis, a secondary infection.
What This Means for Canadian Patients
This case suggests that hyperbaric oxygen therapy could potentially serve as an adjunctive treatment for Canadian patients suffering from severe rhinocerebral mucormycosis. However, more extensive research is needed to confirm its efficacy and role in current treatment protocols.
Canadian Relevance
There is no direct Canadian connection to this study, which was conducted in the United States.
Study Limitations
As a single case study from 1980, the findings are limited in their generalizability and applicability to modern medical practice.